|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/10/22 Adorbs Inc. 8-K:1,2,3,5 2/10/22 14:1.2M Empire Filings/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 382K 2: EX-3.3 Articles of Incorporation/Organization or Bylaws HTML 19K 3: EX-4.1 Instrument Defining the Rights of Security Holders HTML 116K 4: EX-10.1 Material Contract HTML 10K 5: EX-23.1 Consent of Expert or Counsel HTML 7K 9: R1 Cover HTML 43K 12: XML IDEA XML File -- Filing Summary XML 13K 10: XML XBRL Instance -- adorbsinc_8k_htm XML 15K 11: EXCEL IDEA Workbook of Financial Reports XLSX 6K 7: EX-101.LAB XBRL Labels -- adob-20220210_lab XML 97K 8: EX-101.PRE XBRL Presentations -- adob-20220210_pre XML 64K 6: EX-101.SCH XBRL Schema -- adob-20220210 XSD 13K 13: JSON XBRL Instance as JSON Data -- MetaLinks 25± 33K 14: ZIP XBRL Zipped Folder -- 0001829126-22-003433-xbrl Zip 118K
Exhibit 10.1
PROMISSORY NOTE
| $76,109 | September 30, 2021 |
MySpray Therapeutics Inc. (“Maker”) promises to pay to the order of Nichol Martinuik, or his assigns, (“Holder”), the principal sum of $76,109 with no interest thereon from this date, until fully paid All unpaid principal balance of this Note shall be due and payable in full upon demand therefor by Holder.
In the event an action is instituted to enforce or interpret any of the terms of this Note including but not limited to any action or participation by Maker in, or in connection with, a case or proceeding under the Bankruptcy Code or any successor statute, each party shall bear all their own expenses incurred at, before and after trial, appeal or review whether or not taxable as costs, including, without limitation, attorney fees, witness fees (expert and otherwise), deposition costs, copying charges and other expenses.
All parties to this Note hereby waive presentment, dishonor, notice of dishonor, and protest. All parties hereto consent to, and Holder is hereby expressly authorized to make, without notice, any and all renewals, extensions, modifications or waivers of the time for or the terms of payment of any sum or sums due hereunder, or under any documents or instruments relating to or securing this Note, or of the performance of any covenants, conditions or agreements hereof or thereof or the taking or release of collateral securing this Note. Any such action taken by Holder shall not discharge the liability of any party to this Note. This Note may not be modified or amended in any respect except in a writing executed by the party to be charged.
This Note has been executed and delivered in Saskatchewan, Canadian and shall be governed and construed in accordance with the laws of such. Any action to enforce this Note or arising out of or related to this Note shall be heard in the Saskatchewan, Canadian courts to the exclusion of all other venues and Maker hereby irrevocably consents to personal jurisdiction in Saskatchewan, Canadian in connection with any such proceedings.
MAKER:
MYSPRAY THERAPEUTICS, INC.,
a Saskatchewan, Canadian company
| /s/ Nichol Martinuik | |
| Nichol Martinuik, President |
C:
| This ‘8-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on / For Period end: | 2/10/22 | |||
| 9/30/21 | 10-Q | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/20/23 Adorbs Inc. 10-Q 9/30/23 41:2.4M Empire Filings/FA 9/27/23 Soul Biotechnology Corp. 10-Q 6/30/23 41:2.4M Empire Filings/FA 8/07/23 Soul Biotechnology Corp. S-1 41:5.4M Empire Filings/FA 5/15/23 Soul Biotechnology Corp. 10-Q 3/31/23 38:2.2M Empire Filings/FA 10/21/22 Soul Biotechnology Corp. 10-Q 9/30/22 38:2.4M Empire Filings/FA 8/01/22 Soul Biotechnology Corp. 10-Q 6/30/22 38:2.1M Empire Filings/FA 5/10/22 Soul Biotechnology Corp. 10-Q 3/31/22 38:1.8M Empire Filings/FA 4/08/22 Soul Biotechnology Corp. DEF 14C 4/08/22 1:704K Empire Filings/FA 3/30/22 Soul Biotechnology Corp. PRE 14C 3/29/22 1:702K Empire Filings/FA |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/19/18 Soul Biotechnology Corp. S-1 6:1M S2 Filings LLC/FA |